From: An explorative study of school performance and antipsychotic medication
Non-users, n (%) | Antipsychotic users, n (%) | p value (Chi2) | |
---|---|---|---|
Total | 7927 (100) | 45 (100) | |
Prescriptions: | |||
Risperidone | 27 (60.0) | ||
Pipamperone | 8 (17.8) | ||
Aripiprazole | 7 (15.6) | ||
Risperidone + Pipamperone | 2 (4.4) | ||
Quetiapine | 1 (2.2) | ||
Start of treatment: | |||
Late <12 months | 13 (28.9) | ||
Early > 12 months | 32 (71.1) | ||
Subgroups: | |||
Sex | <.05* | ||
Boys | 3748 (47.3) | 36 (80.0) | |
Girls | 4179 (52.7) | 9 (20.0) | |
Ethnicity | .695 | ||
Dutch | 7018 (88.5) | 39 (86.7) | |
Non-Dutch | 909 (11.5) | 6 (13.3) | |
Parent household | .141 | ||
Two-parent household | 6486 (81.8) | 33 (73.3) | |
One-parent household | 1441 (18.2) | 12 (26.7) | |
Household income | .134 | ||
Low | 2674 (33.7) | 20 (44.4) | |
Middle | 3038 (38.3) | 18 (40.0) | |
High | 2215 (27.9) | 7 (15.6) |